The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS)

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2017-08, Vol.263, p.e10-e10
Main Authors: Gaudet, Daniel, Digenio, Andres, Alexander, Vickie, Arca, Marcello, Jones, Alan, Stroes, Erik, Bergeron, Jean, Civeira, Ferdando, Hemphill, Linda, Blom, Dirk, Flaim, Joann, Hughes, Steven, Geary, Richard, Tsimikas, Sotirios, Witztum, Joseph, Bruckert, Eric
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2017.06.059